Search Results for: predictions

Why did Texas A&M ink big deal with stem cell clinic firm Celltex on exosomes?

/ / 4 Comments
Texas-AM-Celltex-deal

The recent news that Texas A&M University has inked a full-blown deal with the direct-to-consumer stem cell clinic firm Celltex struck me as an unusual development. Recently we’ve seen more universities exploring the use of stem cells outside of the traditional FDA clinical trial process that is fundamentally based on an investigational new drug application (IND). Some […]

Why did Texas A&M ink big deal with stem cell clinic firm Celltex on exosomes? Read More »

CRISPRcon guest post: Hope for a brighter future

/
Anna-Everette

By Anna Everette “In our society, we have an addiction to vertical genetic transmission. It’s called sex and having a child who looks like you”. This was perhaps the most memorable quote from the event’s keynote speaker, Greg Simon, Director of the Biden Cancer Initiative. It also happens to highlight the most compelling reason to

CRISPRcon guest post: Hope for a brighter future Read More »

Stem cell fake news driving biotech investors or vice versa…or what?

/ / 5 Comments
US-Stem-Cell-Google-Search-e1495552962354

Is there a proliferating stem cell fake news problem in the biotech world? More broadly, the SEC is cracking down on the mess that is fake biotech news, but what about fake news on stem cell biotechs more specifically? Already in the past year I’ve seen examples of possible stem cell fake news. Hyped press releases (PR)

Stem cell fake news driving biotech investors or vice versa…or what? Read More »

Burt Northwestern Stem Cell MS Trial Part 2: Marketing ‘Cure’-Like Outcomes?

/ / 5 Comments
stem-cells-MS-Northwestern-University

Can science now cure MS in some patients with stem cells or is that near on the horizon? What about stem cells for other serious autoimmune disorders? What are the risks to patients in terms of health, money, and hope? What if patients must find $100,000 or $200,000 just to get into a clinical trial for

Burt Northwestern Stem Cell MS Trial Part 2: Marketing ‘Cure’-Like Outcomes? Read More »

New paper with Leigh Turner shows huge American stem cell clinic industry: 570 locations

/ / 6 Comments
Stem Cell Clinics Map

My colleague Leigh Turner and I today published a new paper in Cell Stem Cell documenting for the first time the American stem cell clinic arena in a comprehensive way, which we found as of February has a remarkable 570 clinic locations via 351 businesses. These numbers are way beyond the predictions of most researchers

New paper with Leigh Turner shows huge American stem cell clinic industry: 570 locations Read More »

ViaCyte on the Rise: First Diabetes Trial Data & Acquires BetaLogics IP

/
VC-01-post-implant-final1-e1503703572933, viacyte

Clinical research on Type I Diabetes is one of the most exciting and promising areas of stem cells and regenerative medicine for human disease. Two of the coolest companies out there in this arena have been ViaCyte and BetaLogics (owned by J&J). For more on ViaCyte see my interview with President and CEO Paul Laikind

ViaCyte on the Rise: First Diabetes Trial Data & Acquires BetaLogics IP Read More »